Immunopharmacology

Structure and functions of the interaction domains of C1r and C1s: keystones of the architecture of the C1 complex
pp. 3-13(11)
Authors: Thielens N.M.; Bersch B.; Hernandez J.-F.; Arlaud G.J.

Modular organization of proteins containing C1q-like globular domain
pp. 15-21(7)
Authors: Kishore U.; Reid K.B.M.

Regulation of complement activation by C-reactive protein
pp. 23-30(8)
Authors: Mold C.; Gewurz H.; Du Clos T.W.

Functional properties of soluble CD21
pp. 31-37(7)
Authors: Fremeaux-Bacchi V.; Kolb J.-P.; Rakotobe S.; Kazatchkine M.D.; Fischer E.M.

Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells: some are involved in tumorigenic and metastatic properties of human melanoma cells
pp. 39-45(7)
Author: Frade R.

Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance
pp. 47-52(6)
Authors: Navratil J.S.; Korb L.C.; Ahearn J.M.

The factor H protein family
pp. 53-60(8)
Authors: Zipfel P.F.; Jokiranta T.S.; Hellwage J.; Koistinen V.; Meri S.

Therapeutic intervention with complement and -glucan in cancer
pp. 61-74(14)
Authors: Ross G.D.; Vetvicka V.; Yan J.; Xia Y.; Vetvickova J.

Molecular remodeling of complement regulatory proteins for xenotransplantation
pp. 75-80(6)
Authors: Seya T.; Mikata S.; Fukui A.; Murakami Y.; Matsumoto M.; Nagasawa S.

Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis
pp. 81-90(10)
Authors: Zhang Y.; Suankratay C.; Zhang X.-H.; Lint T.F.; Gewurz H.

Control of host complement activation by the Echinococcus granulosus hydatid cyst
pp. 91-98(8)
Authors: Daz A.; Irigon F.; Ferreira F.; Sim R.B.

Viral complement regulatory proteins
pp. 99-106(8)
Authors: Rosengard A.M.; M. Ahearn J.

Complement systems in invertebrates. The ancient alternative and lectin pathways
pp. 107-120(14)
Authors: Smith L.C.; Azumi K.; Nonaka M.

The complement regulator C4b-binding protein analyzed by molecular modeling, bioinformatics and computer-aided experimental design
pp. 121-134(14)
Authors: Villoutreix B.O.; Blom A.M.; Webb J.; Dahlback B.

Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA
pp. 135-149(15)
Authors: Circolo A.; Garnier G.; Fukuda W.; Wang X.; Hidvegi T.; Szalai A.J.; Briles D.E.; Volanakis J.E.; Wetsel R.A.; Colten H.R.

Different stimulating effects of complement C3b and complete Freund's adjuvant on antibody response
pp. 151-157(7)
Authors: Villiers M.-B.; Villiers C.L.; Laharie A.-M.; Marche P.N.

Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies
pp. 159-165(7)
Authors: Prechl J.; Tchorbanov A.; Horvath A.; Baiu D.C.; Hazenbos W.; Rajnavolgyi E.; Kurucz I.; Capel P.J.A.; Erdei A.

Decay acceleration of the complement alternative pathway C3 convertase
pp. 167-173(7)
Authors: Hourcade D.E.; Mitchell L.M.; Medof M.E.

Phosphorylation of the complement component, C9, by an ecto-protein kinase of human leukemic cells
pp. 175-185(11)
Authors: Paas Y.; Bohana-Kashtan O.; Fishelson Z.

Tyrosine phosphorylation and activation of Janus kinase 1 and STAT3 by sublytic C5b-9 complement complex in aortic endothelial cells
pp. 187-193(7)
Authors: Niculescu F.; Soane L.; Badea T.; Shin M.; Rus H.

Deposition of complement C3 and factor H in tissue traumatized by burn injury
pp. 195-202(8)
Authors: Sriramarao P.; DiScipio R.G.

Inhibition of human and mouse complement-dependent hemolytic activity by mouse fibronectin
pp. 203-208(6)
Authors: Hitsumoto Y.; Okada M.; Makino H.

Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2
pp. 209-218(10)
Authors: Jurianz K.; Maslak S.; Garcia-Schuler H.; Fishelson Z.; Kirschfink M.

Derivation of RNA aptamer inhibitors of human complement C5
pp. 219-230(12)
Authors: Biesecker G.; Dihel L.; Enney K.; Bendele R.A.

C1-inhibitor attenuates hyperacute rejection and inhibits complement, leukocyte and platelet activation in an ex vivo pig-to-human perfusion model
pp. 231-243(13)
Authors: Fiane A.E.; Videm V.; Johansen H.T.; Mellbye O.J.; Nielsen E.W.; Mollnes T.E.

Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury
pp. 245-254(10)
Authors: Alexander J.J.; Lim A.; He C.; MacDonald R.L.; Holers V.M.; Quigg R.J.